| 产品详情 |
| Edit |   |
|---|
| Product Name | GalNAc-T5, soluble fragment, Human Recombinant |
|---|
| Description | Polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) catalyzes the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the hydroxyl group of serine and threonine residues, and was first cloned from rat. Twenty GalNAc-T genes have been identified in humans and most have been shown to represent active GalNAc-Ts. All isoforms are type II transmembrane proteins, with different but partly overlapping substrate preferences. The GalNAc-Ts control the initiation of mucin-type O-linked glycosylation and determine the location and density of O-glycans in a protein. Addition of GalNAc to an unglycosylated Ser/Thr residue creates the Tn antigen GalNAcα1-S/T, and subsequent addition of sialic acid by ST6GalNAc-I forms the cancer a |
|---|
| Size | 5 µg |
|---|
| Concentration | 477 ug/ml |
|---|
| Applications | RUO |
|---|
| Other Names | Polypeptide N-acetylgalactosaminyltransferase 5, Polypeptide GalNAc transferase 5, GaNTase 5 |
|---|
| Gene, Accession, CAS # | GALNT5, Gene ID: 11227, Accession: Q7Z7M9 |
|---|
| Catalog # | P1217-5 |
|---|
| Price | |
|---|
| Order / More Info | GalNAc-T5, soluble fragment, Human Recombinant from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|